Thomas Frank E

Avg. Two Year Performance

20% Avg. Purchase Return
10% Compound
52% Avg. Sale Return
23% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(5%)(12%)(16%)(15%)20%
Purchase Success Rate2 of 50 of 51 of 52 of 54 of 5
Average Sale Return2%20%53%54%52%
Sale Success Rate2 of 42 of 42 of 42 of 42 of 4

Critical Therapeutics Inc.

Other » Other

President & CEO, Director:

Holdings: 72.03K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

AMAG Pharmaceuticals, Inc.

Drugs » Diagnostic Substances

President & COO:

Holdings: 138.19K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Orchard Therapeutics Plc

Other » Other

See Remarks:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Larimar Therapeutics, Inc.

Drugs » Biotechnology

Director:

Holdings: 2.0K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Spero Therapeutics, Inc.

Other » Other

Director:

Holdings: 35.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--